Circulating microRNA-1a is a biomarker of Graves' disease patients with atrial fibrillation
文献类型:期刊论文
作者 | Wang, Fang4; Tian, Dong-mei4; Zhang, Sheng-jie2; Yao, Xuan2; Ying, Hao2; Zhang, Ke-qin3; She, Dun-min3; Xue, Ying3; Guo, Fei-fan1; Zhai, Qi-wei1 |
刊名 | ENDOCRINE
![]() |
出版日期 | 2017 |
卷号 | 57期号:1页码:125-137 |
关键词 | Graves' disease Thyroid hormone Atrial fibrillation MicroRNA |
ISSN号 | 1355-008X |
DOI | 10.1007/s12020-017-1331-4 |
文献子类 | Article |
英文摘要 | It has been increasingly suggested that specific microRNAs expression profiles in the circulation and atrial tissue are associated with the susceptibility to atrial fibrillation. Nonetheless, the role of circulating microRNAs in Graves' disease patients with atrial fibrillation has not yet been well described. The objective of the study was to identify the role of circulating microRNAs as specific biomarkers for the diagnosis of Graves' disease with atrial fibrillation. The expression profiles of eight serum microRNAs, which are found to be critical in the pathogenesis of atrial fibrillation, were determined in patients with Graves' disease with or without atrial fibrillation. MicroRNA expression analysis was performed by real-time PCR in normal control subjects (NC; n = 17), patients with Graves' disease without atrial fibrillation (GD; n = 29), patients with Graves' disease with atrial fibrillation (GD + AF; n = 14), and euthyroid patients with atrial fibrillation (AF; n = 22). Three of the eight serum microRNAs,i.e., miR-1a, miR-26a, and miR-133, had significantly different expression profiles among the four groups. Spearman's correlation analysis showed that the relative expression level of miR-1a was positively correlated with free triiodothyronine (FT3) and free thyroxine (FT4), and negatively related to thyroid stimulating hormone. Spearman's correlations analysis also revealed that the level of miR-1a was negatively correlated with a critical echocardiographic parameter (left atrial diameter), which was dramatically increased in GD + AF group compared to GD group. Furthermore, the receiver-operating characteristic curve analysis indicated that, among the eight microRNAs, miR-1a had the largest area under the receiver-operating characteristic curves not only for discriminating between individuals with and without Graves' disease, but also for predicting the presence of atrial fibrillation in patients with Graves' disease. Our findings showed that the levels of serum miR-1a were significantly decreased in GD + AF group compared with GD group, suggesting that serum miR-1a might serve as a novel biomarker for diagnosis of atrial fibrillation in patients with Graves' disease. |
学科主题 | Endocrinology & Metabolism |
WOS关键词 | CORONARY-ARTERY-DISEASE ; EXPRESSION PROFILES ; CARDIAC CONDUCTION ; CATHETER ABLATION ; THYROID-HORMONE ; HEART ; IDENTIFICATION ; CHANNELS ; SYSTEM ; RISK |
语种 | 英语 |
WOS记录号 | WOS:000403670300016 |
出版者 | SPRINGER |
版本 | 出版稿 |
源URL | [http://202.127.25.144/handle/331004/922] ![]() |
专题 | 中国科学院上海生命科学研究院营养科学研究所 |
作者单位 | 1.Chinese Acad Sci, Shanghai Inst Biol Sci, Univ Chinese Acad Sci, Inst Nutr Sci,Key Lab Nutr & Metab, Shanghai 200031, Peoples R China, 2.Chinese Acad Sci, Shanghai Inst Biol Sci, Univ Chinese Acad Sci, Inst Nutr Sci,Key Lab food safety Res, Shanghai 200031, Peoples R China; 3.Tongji Univ, Tongji Hosp, Dept Endocrinol, Sch Med, Shanghai 200065, Peoples R China; 4.Peoples Hosp Shanghai, Dept Endocrinol, Shanghai 200060, Peoples R China; |
推荐引用方式 GB/T 7714 | Wang, Fang,Tian, Dong-mei,Zhang, Sheng-jie,et al. Circulating microRNA-1a is a biomarker of Graves' disease patients with atrial fibrillation[J]. ENDOCRINE,2017,57(1):125-137. |
APA | Wang, Fang.,Tian, Dong-mei.,Zhang, Sheng-jie.,Yao, Xuan.,Ying, Hao.,...&,.(2017).Circulating microRNA-1a is a biomarker of Graves' disease patients with atrial fibrillation.ENDOCRINE,57(1),125-137. |
MLA | Wang, Fang,et al."Circulating microRNA-1a is a biomarker of Graves' disease patients with atrial fibrillation".ENDOCRINE 57.1(2017):125-137. |
入库方式: OAI收割
来源:上海营养与健康研究所
浏览0
下载0
收藏0
其他版本
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。